# Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

> **NCT01774435** · PHASE1 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 35 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** EN3342

## Key facts

- **NCT ID:** NCT01774435
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01774435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01774435, "Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01774435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*